Relative bioavailability and bioaccessibility and speciation of arsenic in contaminated soils

Environmental Health Perspectives

Volumn 119, Issue 11, 2011, Pages 1629-1634

  Bradham, Karen D ^a   Scheckel, Kirk G ^b   Nelson, Clay M ^a   Seales, Paul E ^c   Lee, Grace E ^c   Hughes, Michael F ^c   Miller, Bradley W ^b   Yeow, Aaron ^a   Gilmore, Thomas ^a   Serda, Sophia M ^a   Harper, Sharon ^a   Thomas, David J ^c  

^a U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^b U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

^c U S ENVIRONMENTAL PROTECTION AGENCY   (United States)

Author keywords

Arsenic; Bioaccessibility; Bioavailability; Gastrointestinal; Human health; Human health risk assessment; Metalloid; Soil physicochemical properties; Speciation

Indexed keywords

ALUMINUM; ARSENATE SODIUM; ARSENIC; IRON;

ANALYTICAL PARAMETERS; ANIMAL EXPERIMENT; ARTICLE; BIOACCESIBILITY; BIOAVAILABILITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ECOSYSTEM RESTORATION; ENVIRONMENTAL EXPLOITATION; ENVIRONMENTAL EXPOSURE; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MINING; MOUSE; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; REFERENCE VALUE; RISK ASSESSMENT; SMELTING; SOIL ANALYSIS; SOIL CHEMISTRY; SOIL POLLUTION;

ANIMALS; ARSENATES; ARSENIC; BIODEGRADATION, ENVIRONMENTAL; BIOLOGICAL AVAILABILITY; ENVIRONMENTAL MONITORING; FEMALE; METALLURGY; MICE; MICE, INBRED C57BL; MODELS, ANIMAL; RISK ASSESSMENT; SOIL POLLUTANTS; X-RAY ABSORPTION SPECTROSCOPY;

EID: 80455144498     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1003352     Document Type: Article

References (58)

1. Basta NT, Foster JN, Dayton EA, Rodriguez RR, Casteel SW. 2007. The effect of dosing vehicle on arsenic bioaccessibility in smelter-contaminated soils. J Environ Sci Health A Tox Hazard Subst Environ Eng 42:1275-1281.
2. Beak DG, Basta NT, Scheckel KG, Traina SJ. 2006a. Bioaccessibility of arsenic bound to corundum using a simulated gastrointestinal system. Environ Chem 3:208-214.
3. Beak DG, Basta NT, Scheckel KG, Traina SJ. 2006b. Bioaccessibility of arsenic (V) bound to ferrihydrite using a simulated gastrointestinal system. Environ Sci Technol 40:1364-1370.
4. Bowell RJ. 1994. Sorption of arsenic by iron oxides and oxyhydroxides in soils. Appl Geochem 9:279-286.
5. Bradham K, Dayton E, Basta N, Schroder J, Payton M, Lanno R. 2006. Effect of soil properties on lead bioavailability and toxicity to earthworms. Environ Toxicol Chem 25:769-775.
6. Bradham K, Wentsel R. 2010. Scientific issues in the U.S. EPA framework for metals risk assessment. J Toxicol Environ Health 73:1-4.
7. Calabrese EJ, Stanek E, Barnes R. 1996. Methodology to estimate the amount and particle size of soil ingested by children: implications for exposure assessment at waste sites. Regul Toxicol Pharmacol 24:264-268.
8. Calatayud M, Gimeno J, Vélez D, Devesa V, Montoro R. 2010. Characterization of the intestinal absorption of arsenate, monomethylarsonic acid, and dimethylarsinic acid using the Caco-2 cell line. Chem Res Toxicol 23:547-556.
9. Casteel SW, Brown LD, Dunsmore ME, Weis CP, Henningsen GM, Hoffman E, et al. 1997. Relative Bioavailability of Arsenic in Mining Wastes. Denver, CO:U.S. Environmental Protection Agency. Available: http://www.epa.gov/region8/r8risk/pdf/r8_asrba1997.pdf [accessed 2 March 2011].
10. Davis A, Ruby MV, Bergstrom PD. 1991. Bioavailability of arsenic and lead in soils from the Butte, Montana mining district. Environ Sci Technol 26:461-468.
11. Dudka S, Miller WP. 1999. Permissible concentrations of arsenic and lead in soils based on risk assessment. Water Air Soil Pollut 113:127-132.
12. Ehlers LJ, Luthy RG. 2003. Contaminant bioavailability in soils and sediments. Environ Sci Technol 37:295A-302A.
13. El-Masri HA, Kenyon EM. 2008. Development of a human physiologically based pharmacokinetic (PBPK) model for inorganic arsenic and its mono-and di-methylated metabolites. J Pharmacokinet Pharmacodyn 35:31-68.
14. Evans MV, Dowd SM, Kenyon EM, Hughes MF, El-Masri HA. 2008. A physiologically based pharmacokinetic model for intravenous and ingested dimethylarsinic acid in mice. Toxicol Sci 104:250-260.
15. Freeman GB, Schoof RA, Ruby MV, Davis AO, Dill JA, Liao SC, et al. 1995. Bioavailability of arsenic in soil and house dust impacted by smelter activities following oral administration in cynomolgus monkeys. Fundam Appl Toxicol 28:215-222.
16. Gentry PR, Covington TR, Mann S, Shipp AM, Yager JW, Clewell HJ III. 2004a. Physiologically based pharmacokinetic modeling of arsenic in the mouse. J Toxicol Environ Health A 67:43-71.
17. Gentry PR, Haber LT, McDonald TB, Zhao Q, Covington T, Nance P, et al. 2004b. Data for physiologically based pharmacokinetic modeling in neonatal animals: physiological parameters in mice and Sprague-Dawley rats. J Child Health 2:363-411.
18. Gonzalez MJ, Aguilar MV, Martinez Para MC. 1995. Gastrointestinal absorption of inorganic arsenic (V): the effect of concentration and interactions with phosphate and dichromate. Vet Hum Toxicol 37:131-136.
19. Hughes MF, Devesa V, Adair BM, Conklin SD, Creed JT, Styblo M, et al. 2008. Tissue dosimetry, metabolism and excretion of pentavalent and trivalent dimethylated arsenic in mice after oral administration. Toxicol Appl Pharmacol 227:26-35.
20. Hughes MF, Devesa V, Adair BM, Styblo M, Kenyon EM, Thomas DJ. 2005. Tissue dosimetry, metabolism and excretion of pentavalent and trivalent monomethylated arsenic in mice after oral administration. Toxicol Appl Pharmacol 208:186-197.
21. Hughes MF, Edwards BC, Herbin-Davis KM, Saunders J, Styblo M, Thomas DJ. 2010. Arsenic (+3 oxidation state) methyltransferase genotype affects steady-state distribution and clearance of arsenic in arsenate-treated mice. Toxicol Appl Pharmacol 249:217-223.
22. Hughes MF, Kenyon EM, Edwards BC, Mitchell CT, Del Razo LM, Thomas DJ. 2003. Accumulation and metabolism of arsenic in mice after repeated oral administration of arsenate. Toxicol Appl Pharmacol 191:202-210.
23. Hughes MF, Kenyon EM, Edwards BC, Mitchell CT, Thomas DJ. 1999. Strain-dependent disposition of inorganic arsenic in the mouse. Toxicology 137:95-108.
24. Hughes MF, Menache M, Thompson DJ. 1994. Dose-dependent disposition of sodium arsenate in mice following acute oral exposure. Fundam Appl Toxicol 22:80-89.
25. Hughes MF, Thompson DJ. 1996. Subchronic dispositional and toxicological effects of arsenate administered in drinking water to mice. J Toxicol Environ Health 49:177-196.
26. International Agency for Research on Cancer. 2004. Some drinking-water disinfectants and contaminants, including arsenic. IARC Monogr Eval Carcinog Risks Hum 84:1-477.
27. Jenne EA. 1968. Controls on Mn, Fe, Co, Ni, Cu, and Zn concentrations in soils and water: the significant role of hydrous Mn and Fe oxides. Trace Inorg Water 73:337-387.
28. Juhasz AL, Smith E, Weber J, Rees M, Rofe A, Kuchel T, et al. 2007. Comparison of in vivo and in vitro methodologies for the assessment of arsenic bioavailability in contaminated soils. Chemosphere 69:961-966.
29. Juhasz AL, Weber J, Smith E, Naidu R, Rees M, Rofe A, et al. 2009. Assessment of four commonly employed in vitro assays for predicting in vivo relative arsenic bioavailability in contaminated soils. Environ Sci Technol 43:9487-9494.
30. Kelly ME, Brauning SE, Schoof RA, Ruby MV. 2002. Assessing Oral Bioavailability of Metals in Soil. Columbus, OH:Battelle Press.
31. Kenyon EM, Hughes MF, Adair BM, Highfill JH, Crecelius EA, Clewell HJ, et al. 2008. Tissue distribution and urinary excretion of inorganic arsenic and its methylated metabolites in C57BL6 mice following subchronic exposure to arsenate in drinking water. Toxicol Appl Pharmacol 232:448-455.
32. Lorenzana RM, Duncan B, Ketterer M, Lowry J, Simon J, Dawson M, et al. 1996. Bioavailability of Arsenic and Lead in Environmental Substrates. EPA 910/R-96-002. Seattle, WA:U.S. Environmental Protection Agency.
33. McKeague JA, Brydon JE, Miles MN. 1971. Differentiation of forms of extractable iron and aluminum in soils 1. Soil Sci Soc Am J 35:33-38.
34. Nagar R, Sarkar D, Makris KC, Datta R, Sylvia V. 2009. Bioavailability and bioaccessibility of arsenic in a soil amended with drinking water treatment residuals. Arch Environ Contam Toxicol 57:755-766.
35. Ng JC, Kratzmann SM, Qi L, Crawley H, Chiswell B, Moore MR. 1998. Speciation and absolute bioavailability: risk assessment of arsenic-contaminated sites in a residential suburb in Canberra. Analyst 123:889-892.
36. NRC (National Research Council). 2003. Bioavailability of Contaminants in Soils and Sediments: Processes, Tools, and Applications. Washington, DC:National Academy Press.
37. NRC (National Research Council). 2007. Toxicity Testing in the 21st Century: A Vision and a Strategy. Washington, DC:National Academies Press.
38. Pascoe GA, Blanchet RJ, Linder G. 1994. Bioavailability of metals and arsenic to small mammals at a mining waste-contaminated wetland. Arch Environ Contam Toxicol 1:44-50.
39. Pinyayev TS, Kohan MJ, Herbin-Davis K, Creed JT, Thomas DJ. 2011. Preabsorptive metabolism of sodium arsenate by anaerobic microbiota of mouse cecum forms a variety of methylated and thiolated arsenicals. Chem Res Toxicol 24(4):475-477.
40. Rees M, Sansom L, Rofe A, Juhasz A, Smith E, Weber J, et al. 2009. Principles and application of an in vivo swine assay for the determination of arsenic bioavailability in contaminated matrices. Environ Geochem Health 31:167-177.
41. Reeves PG, Nielsen FH, Fahey GC. 1993. AIN-93 purified diets for laboratory rodents: final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76A rodent diet. J Nutr 123:1939-1951.
42. Roberts SM, Munson JW, Lowney YW, Ruby MV. 2007. Relative oral bioavailability of arsenic from contaminated soils measured in the cynomolgus monkey. Toxicol Sci 95:281-288.
43. Roberts SM, Weimar WR, Vinson JR, Munson JW, Bergeron RJ. 2002. Measurement of arsenic bioavailability in soil using a primate model. Toxicol Sci 67:303-310.
44. Rodriguez RR, Basta NT, Casteel SW, Pace LW. 1999. An in vitro gastrointestinal method to estimate bioavailable arsenic in contaminated soils and solid media. Environ Sci Technol 33:642-649.
45. Ruby MV, Schoof R, Brattin W, Goldade M, Post G, Harnois M, et al. 1999. Advances in evaluating the oral bioavailability of inorganics in soil for use in human health risk assessment. Environ Sci Technol 33:3697-3705.
46. Scheckel KG, Chaney RL, Basta NT, Ryan JA. 2009. Advances in assessing bioavailability of metal(loids) in contaminated soils. Adv Agron 104:1-52.
47. Turnbaugh PJ, Ridaura VK, Faith JJ, Rey FE, Knight R, Gordon JI. 2009. The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice. Sci Transl Med 1(6):6ra14; doi:10.1126/scitranslmed.3000322 [Online 11 November 2009].
48. U.S. EPA (U.S. Environmental Protection Agency). 1989. Risk Assessment Guidance for Superfund Volume 1: Human Health Evaluation Manual (Part A). EPA/540/1-89/002. Washington, DC:U.S. EPA, Office of Emergency and Remedial Response.
49. U.S. EPA (U.S. Environmental Protection Agency). 2001. CERCLIS 3 Database. Washington, DC:U.S. EPA, Office of Solid Waste and Emergency Response.
50. U.S. EPA (U.S. Environmental Protection Agency). 2007. Estimation of Relative Bioavailability of Lead in Soil and Soil-like Materials Using in Vivo and in Vitro Methods. OSWER 9285.7-77. Washington, DC:U.S. EPA, Office of Solid Waste and Emergency Response.
51. U.S. EPA (U.S. Environmental Protection Agency). 2007. Framework for Metals Risk Assessment. EPA 120/R-07/001. Washington, DC:U.S. EPA.
52. U.S. EPA (U.S. Environmental Protection Agency). 2007. Guidance for Evaluating the Oral Bioavailability of Metals in Soils for Use in Human Health Risk Assessment. OSWER 9285.7-80. Washington, DC:U.S. EPA, Office of Solid Waste and Emergency Response.
53. U.S. EPA (U.S. Environmental Protection Agency). 2007. Method 3051A: Microwave Assisted Acid Digestion of Sediments, Sludges, Soils, and Oils. Washington, DC:U.S. EPA, Office of Solid Waste. Available: http://www.epa.gov/osw/hazard/testmethods/sw846/pdfs/3051a.pdf [accessed 2 March 2011).
54. U.S. EPA (U.S. Environmental Protection Agency). 2007. Method 6010C: Inductively Coupled Plasma-Atomic Emission Spectrometry. Washington, DC:U.S. EPA, Office of Solid Waste. Available: http://www.epa.gov/osw/hazard/testmethods/sw846/pdfs/6010c.pdf [accessed 2 March 2011].
55. U.S. EPA (U.S. Environmental Protection Agency). 2009. Relative bioavailability of arsenic in NIST 2710 (Montana soil) (Internal Report). Washington, DC:U.S. EPA, Office of Superfund Remediation Technology Innovation.
56. Vahter M. 1999. Methylation of inorganic arsenic in different mammalian species and population groups. Sci Prog 82:69-88.
57. Xie Y, Liu J, Liu Y, Klaassen CD, Waalkes MP. 2004. Toxicokinetic and genomic analysis of chronic arsenic exposure in multidrug-resistance mdr1a/1b(-/-) double knockout mice. Mol Cell Biochem 255:11-18.
58. Yang J, Barnett MO, Jardine PM, Basta NT, Casteel SW. 2002. Adsorption, sequestration, and bioaccessibility of As(V) in soils. Environ Sci Technol 36:4562-4569.